Risk assessment and counseling behaviors of healthcare professionals managing patients with chronic pain: A national multifaceted assessment of physicians, pharmacists, and their patients

Journal of Opioid Management

Volumn 8, Issue 5, 2012, Pages 273-284

  Salinas, Gregory D ^a   Susalka, Debi ^a   Burton, B Stephen ^a   Roepke, Nancy ^a   Evanyo, Kimberly ^b   Biondi, David ^b   Nicholson, Susan ^b  

^a CE Outcomes LLC   (United States)

^b JANSSEN RESEARCH AND DEVELOPMENT   (United States)

Author keywords

Chronic pain; Counseling; Opioids; Practice patterns; Risk assessment

Indexed keywords

OPIATE;

ADULT; ANALGESIA; ARTICLE; CHRONIC PAIN; CLINICAL PRACTICE; DRUG SAFETY; DRUG STORAGE; DRUG TREATMENT FAILURE; DRUG UTILIZATION; FEMALE; GENERAL PRACTITIONER; HEALTH PERSONNEL ATTITUDE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MEDICAL SPECIALIST; PAIN ASSESSMENT; PATIENT CARE; PATIENT COUNSELING; PATIENT MONITORING; PHARMACIST; PROFESSIONAL KNOWLEDGE; RISK ASSESSMENT; URINALYSIS;

ADULT; AGED; ANALGESICS, OPIOID; CHRONIC PAIN; COUNSELING; FEMALE; HUMANS; MALE; MIDDLE AGED; PHARMACISTS; PHYSICIANS, PRIMARY CARE; RISK ASSESSMENT;

EID: 84866745644     PISSN: 15517489     EISSN: None     Source Type: Journal    
DOI: 10.5055/jom.2012.0127     Document Type: Article

References (14)

1. Smith BH, Elliott AM, Chambers WA, et al.: The impact of chronic pain in the community. Fam Pract. 2001; 18: 292-299.
2. The Mayday Fund: A call to revolutionize chronic pain care in America: An opportunity in health care reform chronic pain in 2010. Available at http://www.maydaypainreport.org/report.php. Accessed June 14, 2012.
3. Alliance of State Pain Initiatives (ASIP): Professional pain education. Available at http://aspi.wisc.edu/. Accessed June 14, 2012.
4. Chou R, Fanciullo GJ, Fine PG, et al.: Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain. 2009; 10(2): 113-130.
5. Passik SD, Kirsh KL: The need to identify predictors of aberrant drug-related behavior and addiction in patients being treated with opioids for pain. Pain Med. 2003; 4(2): 186-189.
6. Peabody JW, Luck J, Glassman P, et al.: Comparison of vignettes, standardized patients, and chart abstraction: A prospective validation study of 3 methods for measuring quality. JAMA. 2000; 283: 1715-1722.
7. Peabody JW, Luck J, Glassman P, et al.: Measuring the quality of physician practice by using clinical vignettes: A prospective validation study. Ann Intern Med. 2004; 141: 771-780.
8. US Department of Health and Human Services, Food and Drug Administration: Draft blueprint for prescriber education for long-acting/extended-release opioid class-wide risk evaluation and mitigation strategy; availability; request for comments. Available at http://www.gpo.gov/fdsys/pkg/FR-2011-11-07/pdf/2011- 28669.pdf. Accessed June 14, 2012.
9. Nafziger AN, Bertino JS: Utility and application of urine drug testing in chronic pain management with opioids. Clin J Pain. 2009; 25(1): 73-79.
10. Christo PJ, Manchikanti L, Ruan X, et al.: Urine drug testing in chronic pain. Pain Physician. 2011; 14(2): 123-143.
11. Reisfield GM, Salazar E, Bertholf RL: Rational use and interpretation of urine drug testing in chronic opioid therapy. Ann Clin Lab Sci. 2007; 37(4): 301-314.
12. Laffer Associates and Millennium Research Institute: An economic analysis of the costs and benefits associated with regular urine drug testing for chronic pain patients in the United States. Available at http://www. millenniumresearchinstitute.org/wpcontent/uploads/2011/10/Full-Study-Laffer-MRI- Economic-Analysis-of-UDT-Released-2011-10-03.pdf. Accessed October 27, 2011.
13. Substance Abuse and Mental Health Services Administration: Results from the 2010 National Survey on Drug Use and Health: Summary of National Findings, NSDUH Series H-41, HHS Publication No. (SMA) 11-4658. Rockville, MD: Substance Abuse and Mental Health Services Administration, 2011.
14. Chen L, Houghton M, Seefeld L, et al.: Opioid therapy for chronic pain: Physicians' attitude and current practice patterns. J Opioid Manage. 2011; 7: 267-276.